Loading…
Based on limited metadata, this warning letter was issued to Sofie Co. (operating as Sofie) on October 10, 2019, regarding pharmaceutical drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided.